Vivani Medical Inc. VANI 深 沪
已收盘 07-02 16:00:00 美东时间
1.26
+0.030
+2.44%
华盛通- 最 高1.35
- 今 开1.24
- 成交量 133.77万股
- 最 低 1.23
- 昨 收 1.23
- 总市值 1.09亿
- 52周最高 1.92
- 市盈率 静 --
- 换手率 1.55%
- 52周最低 0.9228
- 委 比 75.00%
- 总股本 8623.51万
- 历史最高 576.48
- 量 比 9.21
- 振 幅 9.76%
- 历史最低 0.7536
- 每 手 1
- 风险率 0.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ClearOne To Acquire Vivani Medical Subsidiary Cortigent For 12.5M Shares Of CLRO Worth ~$40.4M; ClearOne To File S-1 Seeking To Raise $10M-$15M
Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it has entered into a definitive agreement and plan of merger (the "Agreement") among its wholly owned subsidiary Cortigent, Inc. ("Co...
07-02 20:03
美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
06-24 14:08
Lake Street Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $4
Lake Street analyst Thomas Flaten initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $4.
06-23 22:24
Vivani Medical publishes investor presentation on NanoPortal long-acting GLP-1 implant strategy for obesity market
Vivani Medical publishes investor presentation on NanoPortal long-acting GLP-1 implant strategy for obesity market Vivani outlined its NanoPortal ultra long-acting, removable subdermal GLP-1 implant platform targeting once- or twice-yearly dosing. Lead candidate NPM-139, a semaglutide implant for ch
06-04 22:07
Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.
Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 18.18 percent increase over losses of $(0.11) per share from the
03-27 04:49
Vivani Medical Director Gregg Williams reports acquisition of Vivani Medical common shares worth USD 1.68 million
Vivani Medical Director Gregg Williams reports acquisition of Vivani Medical common shares worth USD 1.68 million Gregg Williams, a director and 10% owner of Vivani Medical, reported acquiring 1,575,231 common shares through private purchase transactions. The shares were acquired at prices of USD 1.
03-16 18:16
Director and 10% Owner Gregg Williams Acquires Common Shares of Vivani Medical Inc
Director and 10% Owner Gregg Williams Acquires Common Shares of Vivani Medical Inc Gregg Williams, a director and 10% owner, reported the acquisition of common shares of Vivani Medical Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Tech
02-17 19:12
Vivani's Brain Implant Helps Blind Patients See Light And Movement In 6-Year Study
Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that Cortigent, Inc. ("Cortigent"), its
01-29 20:35
Cortigent Reports Promising Six-Year Results for Orion Visual Prosthesis
Cortigent Reports Promising Six-Year Results for Orion Visual Prosthesis Vivani Medical Inc. announced that its wholly-owned subsidiary, Cortigent, Inc., presented promising six-year early feasibility study results for the Orion® Visual Cortical Prosthesis System at the North American Neuromodulatio
01-29 20:30
Vivani Medical Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares
Vivani Medical Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares Gregg Williams, a Director and 10% Owner of Vivani Medical Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief
01-28 23:01
